Isomorphic Labs Secures $600M to Advance AI Drug Design
Isomorphic Labs, a spinout from DeepMind, has raised $600 million in its first external funding round. The round was led by Thrive Capital, with participation from Google Ventures and Alphabet. This funding aims to accelerate the development of Isomorphic Labs' AI drug design engine and advance its drug candidates to clinical trials by the end of the year.
The company, headquartered in London with an office in Lausanne, Switzerland, is focused on reducing the time required to discover new medicines. It leverages DeepMind's AlphaFold technology to predict protein interactions with other molecules, applying this to a broader range of biological molecules. Isomorphic Labs has partnered with pharmaceutical giants like Eli Lilly and Novartis and is primarily focused on oncology and immunology.
Demis Hassabis, founder and CEO of Isomorphic Labs, stated that the funding will enhance their AI research and development efforts and expand their team. The company has been on a rapid growth trajectory since its inception in 2021, having quadrupled its R&D spending in 2023.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
More from: Funding
Anaqua Acquires RightHub to Expand IP Management Solutions
A100x Launches $50 Million Fund for AI and Blockchain Startups
CrediLinq Secures $8.5M Series A for B2B Embedded Finance Expansion
1848 Ventures Acquires Luminest to Boost AI-Powered SaaS Strategy
Scrypted Acquires Chibi Clash to Enhance AI-Powered Gaming
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more